Lifecore Biomedical, Inc. De annual shareholders’ equity
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2025
Lifecore Biomedical, Inc. De Shareholders’ Equity Growth & History (LFCR)
Lifecore Biomedical, Inc. De's shareholders’ equity was −$14.2M for fiscal 2025.
View full Lifecore Biomedical, Inc. De company overviewLifecore Biomedical, Inc. De annual shareholders’ equity history
| Fiscal year | Period ended | Shareholders’ equity | Change | Growth |
|---|---|---|---|---|
| 2025 · Dec 31 | 2025-12-31 | −$14.2M | — | — |
| 2025 · May 25 | 2025-05-25 | $1.3M | −$10.0M | −88.19% |
| 2024 | 2024-05-26 | $11.3M | $15.5M | — |
| 2023 | 2023-05-28 | −$4.2M | −$92.1M | — |
| 2022 | 2022-05-29 | $87.8M | −$114.1M | −56.51% |
| 2021 | 2021-05-30 | $201.9M | −$27.9M | −12.13% |
| 2020 | 2020-05-31 | $229.8M | −$40.3M | −14.92% |
| 2019 | 2019-05-26 | $270.1M | $17.6M | +6.96% |
| 2018 | 2018-05-27 | $252.6M | $26.0M | +11.45% |
| 2017 | 2017-05-28 | $226.6M | $15.9M | +7.54% |
| 2016 | 2016-05-29 | $210.7M | −$7.7M | −3.53% |
| 2015 | 2015-05-31 | $218.4M | $15.4M | +7.57% |
| 2014 | 2014-05-25 | $203.1M | $24.4M | +13.64% |
| 2013 | 2013-05-28 | $178.7M | $29.0M | +19.33% |
| 2012 | 2012-05-27 | $149.7M | $13.7M | +10.06% |
| 2011 | 2011-05-29 | $136.1M | — | — |
Lifecore Biomedical, Inc. De quarterly shareholders’ equity
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q2.13
Q3.13
As of May 26, 2013
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Shareholders’ equity | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$34.1M | — | — |
| Q1 2026 | 2026-03-31 | −$28.4M | — | — |
| Q4 2025 · Dec 31 | 2025-12-31 | −$14.2M | — | — |
| Q3 2025 · Sep 30 | 2025-09-30 | −$10.5M | — | — |
| Q4 2025 · May 25 | 2025-05-25 | $1.3M | −$10.0M | −88.19% |
| Q3 2025 · Feb 23 | 2025-02-23 | $2.2M | −$15.5M | −87.44% |
| Q2 2025 | 2024-11-24 | $15.4M | $14.0M | +987.19% |
| Q1 2025 | 2024-08-25 | −$3.9M | $9.6M | — |
| Q4 2024 | 2024-05-26 | $11.3M | $15.5M | — |
| Q3 2024 | 2024-02-25 | $17.7M | −$17.3M | −49.50% |
| Q2 2024 | 2023-11-26 | $1.4M | −$72.7M | −98.08% |
| Q1 2024 | 2023-08-27 | −$13.6M | −$93.9M | — |
| Q4 2023 | 2023-05-28 | −$4.2M | −$92.1M | — |
| Q3 2023 | 2023-02-26 | $35.0M | −$108.7M | −75.63% |
| Q2 2023 | 2022-11-27 | $74.2M | −$82.0M | −52.52% |
| Q1 2023 | 2022-08-28 | $80.4M | −$113.5M | −58.55% |
| Q4 2022 | 2022-05-29 | $87.8M | −$114.1M | −56.51% |
| Q3 2022 | 2022-02-27 | $143.7M | −$60.9M | −29.76% |
| Q2 2022 | 2021-11-28 | $156.2M | −$52.7M | −25.24% |
| Q1 2022 | 2021-08-29 | $193.9M | −$27.3M | −12.34% |
| Q4 2021 | 2021-05-30 | $201.9M | −$27.9M | −12.13% |
| Q3 2021 | 2021-02-28 | $204.6M | −$43.0M | −17.38% |
| Q2 2021 | 2020-11-29 | $208.9M | −$50.1M | −19.35% |
| Q1 2021 | 2020-08-30 | $221.2M | −$43.8M | −16.53% |
| Q4 2020 | 2020-05-31 | $229.8M | −$40.3M | −14.92% |
| Q3 2020 | 2020-02-23 | $247.7M | −$22.4M | −8.29% |
| Q2 2020 | 2019-11-24 | $259.1M | $5.5M | +2.17% |
| Q1 2020 | 2019-08-25 | $264.9M | $11.6M | +4.56% |
| Q4 2019 | 2019-05-26 | $270.1M | $17.6M | +6.96% |
| Q3 2019 | 2019-02-24 | $270.1M | $21.4M | +8.62% |
| Q2 2019 | 2018-11-25 | $253.6M | $22.4M | +9.68% |
| Q1 2019 | 2018-08-26 | $253.4M | $23.8M | +10.38% |
| Q4 2018 | 2018-05-27 | $252.6M | $26.0M | +11.45% |
| Q3 2018 | 2018-02-25 | $248.6M | $26.0M | +11.69% |
| Q2 2018 | 2017-11-26 | $231.2M | $13.2M | +6.05% |
| Q1 2018 | 2017-08-27 | $229.6M | $14.3M | +6.63% |
| Q4 2017 | 2017-05-28 | $226.6M | $15.9M | +7.54% |
| Q3 2017 | 2017-02-26 | $222.6M | $17.6M | +8.56% |
| Q2 2017 | 2016-11-27 | $218.0M | −$7.1M | −3.17% |
| Q1 2017 | 2016-08-28 | $215.3M | −$7.0M | −3.15% |
| Q4 2016 | 2016-05-29 | $210.7M | −$7.7M | −3.53% |
| Q3 2016 | 2016-02-28 | $205.1M | −$8.8M | −4.12% |
| Q2 2016 | 2015-11-29 | $225.1M | $15.6M | +7.46% |
| Q1 2016 | 2015-08-30 | $222.3M | $16.5M | +8.03% |
| Q4 2015 | 2015-05-31 | $218.4M | $15.4M | +7.57% |
| Q3 2015 | 2015-03-01 | $213.9M | $15.9M | +8.01% |
| Q2 2015 | 2014-11-30 | $209.5M | $20.8M | +11.05% |
| Q1 2015 | 2014-08-31 | $205.8M | $22.1M | +12.02% |
| Q4 2014 | 2014-05-25 | $203.1M | — | — |
| Q3 2014 | 2014-02-23 | $198.0M | $25.0M | +14.45% |
| Q2 2014 | 2013-11-24 | $188.7M | $22.6M | +13.58% |
| Q1 2014 | 2013-08-25 | $183.7M | — | — |
| Q4 2013 | 2013-05-28 | $178.7M | $29.0M | +19.33% |
| As of May 26, 2013 | 2013-05-26 | $178.7M | $29.0M | +19.33% |
| Q3 2013 | 2013-02-24 | $173.0M | $25.1M | +16.98% |
| Q2 2013 | 2012-11-25 | $166.1M | $25.3M | +18.00% |
| Q4 2012 | 2012-05-27 | $149.7M | $13.7M | +10.06% |
| Q3 2012 | 2012-02-26 | $147.9M | — | — |
| Q2 2012 | 2011-11-27 | $140.8M | — | — |
| Q1 2012 | 2011-08-28 | $139.5M | — | — |
| Q4 2011 | 2011-05-29 | $136.1M | — | — |
Lifecore Biomedical, Inc. De shareholders’ equity trends
Between the periods ended 2011-05-29 and 2025-12-31, Lifecore Biomedical, Inc. De's shareholders’ equity decreased from $136.1M to −$14.2M, a change of −$150.3M. The latest reported quarter, Q2 2026, shows −$34.1M.
About the metric
What shareholders’ equity means
Shareholders’ equity is the residual accounting value attributable to shareholders after liabilities are subtracted from assets. It can change through earnings, losses, dividends, share issuance, repurchases, and other comprehensive income.
Calculation and source
SEC-reported shareholders’ equity
TickerStat standardizes stockholders’ or shareholders’ equity reported in company SEC filings at each balance-sheet date. Negative equity is retained because it can be economically meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Lifecore Biomedical, Inc. De source filings ↗